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Introduction 
Many haematological malignancy survivors report long-term post-treatment physiological 
and psychosocial effects. 
Objectives 
This study examined cancer nurses’ perception of their role, confidence levels, practices and 
barriers in relation to survivorship care provision for patients with haematological 
malignancies. 
Methods 
Approximately 1300 cancer nurses were invited to participate in a survey. The survey was 
distributed to all cancer nurses at a Queensland tertiary cancer centre and via email through 
two Australian professional cancer nursing bodies. 
Results 
In total, 423 cancer nurses (33%) completed the survey. The majority of participants agreed 
that all survivorship interventions included in the survey should be within their role. Nurses 
were least confident in discussing fertility (M=5.93, SD=2.66), employment and financial 
issues with patients (M=6.19, SD=2.66) and discussing information about identifying signs of 
cancer recurrence (M=6.43, SD=2.69), on a 11-point scale from 0 to 10 with higher scores 
indicating greater confidence. The least frequently performed interventions included 
discussing fertility, intimacy and sexuality issues, and communicating survivorship care with 
the patient’s primary care 
providers, with over 60% of participants reporting not performing these interventions often. 
The most significant barriers perceived by participants were lack of dedicated end-of-
treatment consultation (M=2.62, SD=1.13), time (M=2.58, SD=0.94), and an appropriate 
physical location (M=2.21, SD=1.01), on a 5-point scale (0=not at all; 4=a great deal). 
Conclusions 
The strong support from nurses for their role in survivorship care highlights opportunities that 
have not yet been adequately developed. Barriers identified in this survey should be 
considered in the design of future survivorship care models. 
